Loprazolam Stats & Data
Dormonoct
NPS DataHub
MW464.91
FormulaC23H21ClN6O3
CAS61197-73-7
IUPAC(2''Z'')-6-(2-Chlorophenyl)-2-[(4-methyl-1-piperazinyl)methylene]-8-nitro-2,4-dihydro-1''H''-imidazo[1,2-''a''][1,4]benzodiazepin-1-one
SMILES
CN1CCN(CC1)C=C1N=C2CN=C(c3ccccc3Cl)c3cc(N(=O)=O)ccc3N2C1=OInChIKey
UTEFBSAVJNEPTR-RGEXLXHISA-N
Chemical Class
Benzodiazepine
Psychoactive Class
Depressant
Pharmacology
DrugBankDescription
Loprazolam is an imidazobenzodiazepine with anxiolytic, anticonvulsant, hypnotic, sedative and skeletal muscle relaxant properties. It is indicated for the short-term treatment of insomnia including difficulty in falling asleep and/or frequent nocturnal awakenings. Loprazolam is recommended as a short-term therapy only, due to adverse events associated with the drug including dependence and withdrawal symptoms. It is a positive modulator of GABA-A receptor that enhances the inhibitory neurotransmission. It is not an FDA-approved drug.
Effect Profile
Curated
Benzodiazepine
7.6
Strong euphoria and anxiolysis with mild sedation, low cognitive impairment
Anxiolysis×3
8
Sedation / Relaxation×2
5
Motor / Cognitive Impairment×1
1
Euphoria / Mood Lift×1
10
Based on reports from:
Tolerance & Pharmacokinetics
drugs.wikiTolerance Decay
Full tolerance
3d
Half tolerance
37d
Baseline
~60d